
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Regulatory circuits of T cell function in cancer
Daniel E. Speiser, Ping‐Chih Ho, Grégory Verdeil
Nature reviews. Immunology (2016) Vol. 16, Iss. 10, pp. 599-611
Closed Access | Times Cited: 499
Daniel E. Speiser, Ping‐Chih Ho, Grégory Verdeil
Nature reviews. Immunology (2016) Vol. 16, Iss. 10, pp. 599-611
Closed Access | Times Cited: 499
Showing 1-25 of 499 citing articles:
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1267-1284
Open Access | Times Cited: 1755
Hugo González, Catharina Hagerling, Zena Werb
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1267-1284
Open Access | Times Cited: 1755
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, et al.
Cell (2018) Vol. 175, Iss. 4, pp. 998-1013.e20
Open Access | Times Cited: 1631
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard, et al.
Cell (2018) Vol. 175, Iss. 4, pp. 998-1013.e20
Open Access | Times Cited: 1631
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 359-367
Open Access | Times Cited: 1107
Hans Raskov, Adile Orhan, Jan Pravsgaard Christensen, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 2, pp. 359-367
Open Access | Times Cited: 1107
Targeted agents and immunotherapies: optimizing outcomes in melanoma
Jason J. Luke, Keith T. Flaherty, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 8, pp. 463-482
Closed Access | Times Cited: 1089
Jason J. Luke, Keith T. Flaherty, Antoni Ribas, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 8, pp. 463-482
Closed Access | Times Cited: 1089
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
Julien Racle, Kaat de Jonge, Petra Baumgaertner, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 1061
Julien Racle, Kaat de Jonge, Petra Baumgaertner, et al.
eLife (2017) Vol. 6
Open Access | Times Cited: 1061
T Cell Dysfunction in Cancer
Daniela S. Thommen, Ton N. Schumacher
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 547-562
Open Access | Times Cited: 1007
Daniela S. Thommen, Ton N. Schumacher
Cancer Cell (2018) Vol. 33, Iss. 4, pp. 547-562
Open Access | Times Cited: 1007
Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death
Wei Li, Jie Yang, Lihua Luo, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 903
Wei Li, Jie Yang, Lihua Luo, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 903
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Stéphane Chevrier, Jacob Levine, Vito Riccardo Tomaso Zanotelli, et al.
Cell (2017) Vol. 169, Iss. 4, pp. 736-749.e18
Open Access | Times Cited: 894
Stéphane Chevrier, Jacob Levine, Vito Riccardo Tomaso Zanotelli, et al.
Cell (2017) Vol. 169, Iss. 4, pp. 736-749.e18
Open Access | Times Cited: 894
Targeting immunosuppressive adenosine in cancer
Dipti Vijayan, Arabella Young, Michele W.L. Teng, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 12, pp. 709-724
Closed Access | Times Cited: 675
Dipti Vijayan, Arabella Young, Michele W.L. Teng, et al.
Nature reviews. Cancer (2017) Vol. 17, Iss. 12, pp. 709-724
Closed Access | Times Cited: 675
CD8+ T cell differentiation and dysfunction in cancer
Mary Philip, Andrea Schietinger
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 209-223
Open Access | Times Cited: 671
Mary Philip, Andrea Schietinger
Nature reviews. Immunology (2021) Vol. 22, Iss. 4, pp. 209-223
Open Access | Times Cited: 671
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma, Liuling Xiao, Lintao Liu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 1001-1012.e5
Open Access | Times Cited: 623
Xingzhe Ma, Liuling Xiao, Lintao Liu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 5, pp. 1001-1012.e5
Open Access | Times Cited: 623
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 613
Yonina R. Murciano‐Goroff, Allison Betof Warner, Jedd D. Wolchok
Cell Research (2020) Vol. 30, Iss. 6, pp. 507-519
Open Access | Times Cited: 613
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
Xiaoyun Li, Mathias Wenes, Pedro Romero, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 7, pp. 425-441
Closed Access | Times Cited: 575
Xiaoyun Li, Mathias Wenes, Pedro Romero, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 7, pp. 425-441
Closed Access | Times Cited: 575
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, et al.
Immunity (2019) Vol. 50, Iss. 6, pp. 1498-1512.e5
Open Access | Times Cited: 544
Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, et al.
Immunity (2019) Vol. 50, Iss. 6, pp. 1498-1512.e5
Open Access | Times Cited: 544
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
Tina Cascone, Jodi A. McKenzie, Rina M. Mbofung, et al.
Cell Metabolism (2018) Vol. 27, Iss. 5, pp. 977-987.e4
Open Access | Times Cited: 504
Tina Cascone, Jodi A. McKenzie, Rina M. Mbofung, et al.
Cell Metabolism (2018) Vol. 27, Iss. 5, pp. 977-987.e4
Open Access | Times Cited: 504
Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 497
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 497
TIP: A Web Server for Resolving Tumor Immunophenotype Profiling
Liwen Xu, Chunyu Deng, Bo Pang, et al.
Cancer Research (2018) Vol. 78, Iss. 23, pp. 6575-6580
Open Access | Times Cited: 491
Liwen Xu, Chunyu Deng, Bo Pang, et al.
Cancer Research (2018) Vol. 78, Iss. 23, pp. 6575-6580
Open Access | Times Cited: 491
Multidimensional communication in the microenvirons of glioblastoma
Marike L. D. Broekman, Sybren L. N. Maas, Erik R. Abels, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 8, pp. 482-495
Open Access | Times Cited: 482
Marike L. D. Broekman, Sybren L. N. Maas, Erik R. Abels, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 8, pp. 482-495
Open Access | Times Cited: 482
Arginase: A Multifaceted Enzyme Important in Health and Disease
R. William Caldwell, Paulo C. Rodrı́guez, Haroldo A. Toque, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 641-665
Open Access | Times Cited: 390
R. William Caldwell, Paulo C. Rodrı́guez, Haroldo A. Toque, et al.
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 641-665
Open Access | Times Cited: 390
The spectrum of T cell metabolism in health and disease
Glenn R. Bantug, Lorenzo Galluzzi, Guido Kroemer, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 19-34
Closed Access | Times Cited: 363
Glenn R. Bantug, Lorenzo Galluzzi, Guido Kroemer, et al.
Nature reviews. Immunology (2017) Vol. 18, Iss. 1, pp. 19-34
Closed Access | Times Cited: 363
The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity
Chengxian Xu, Shaogang Sun, Travis S. Johnson, et al.
Cell Reports (2021) Vol. 35, Iss. 11, pp. 109235-109235
Open Access | Times Cited: 334
Chengxian Xu, Shaogang Sun, Travis S. Johnson, et al.
Cell Reports (2021) Vol. 35, Iss. 11, pp. 109235-109235
Open Access | Times Cited: 334
Rational combination of oncolytic vaccinia virus and PD-L1 blockade works synergistically to enhance therapeutic efficacy
Zuqiang Liu, Roshni Ravindranathan, Paweł Kaliński, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 311
Zuqiang Liu, Roshni Ravindranathan, Paweł Kaliński, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 311
Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
Rachel Thomas, Weikan Wang, Dong‐Ming Su
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 310
Rachel Thomas, Weikan Wang, Dong‐Ming Su
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 310
Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 305
Bernhard Englinger, Christine Pirker, Petra Heffeter, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1519-1624
Open Access | Times Cited: 305
Metabolic and epigenetic regulation of T-cell exhaustion
Fabien Franco, Alison Jaccard, Pedro Romero, et al.
Nature Metabolism (2020) Vol. 2, Iss. 10, pp. 1001-1012
Closed Access | Times Cited: 284
Fabien Franco, Alison Jaccard, Pedro Romero, et al.
Nature Metabolism (2020) Vol. 2, Iss. 10, pp. 1001-1012
Closed Access | Times Cited: 284